Local progression after computed tomography-guided microwave ablation in non-small cell lung cancer patients: prediction using a nomogram model

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783–791.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Mazzone P. Preoperative evaluation of the lung resection candidate. Cleve Clin J Med. 2012;79 Electronic Suppl 1(Electronic Suppl 1):eS17–22.
   Google Scholar
• National Comprehensive Cancer Network (NCCN). 2021. Clinical practice guidelines in oncology. Non-small cell lung cancer, version 2. [cited 15 Dec 2020]. Available from: www.nccn.org/patients
   Google Scholar
• Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv1–21.
   PubMed Web of Science ®Google Scholar
• Donington J, Ferguson M, Mazzone P, et al. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012;142(6):1620–1635.
   PubMed Web of Science ®Google Scholar
• Macchi M, Belfiore MP, Floridi C, et al. Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol. 2017;34(5):96.
   PubMed Web of Science ®Google Scholar
• Genshaft SJ, Suh RD, Abtin F, et al. Society of interventional radiology quality improvement standards on percutaneous ablation of non-small cell lung cancer and metastatic disease to the lungs. J Vasc Interv Radiol. 2021;32(8):1242.e1–1242.e10.
   Web of Science ®Google Scholar
• Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer-Am Cancer Soc. 2006;107(12):2873–2880.
   PubMed Web of Science ®Google Scholar
• Palussiere J, Lagarde P, Auperin A, et al. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years’ experience in 87 patients from two centers. Cardiovasc Intervent Radiol. 2015;38(1):160–166.
   PubMed Web of Science ®Google Scholar
• Hiraki T, Gobara H, Iguchi T, et al. Radiofrequency ablation for early-stage nonsmall cell lung cancer. Biomed Res Int. 2014;2014:152087.
   PubMed Web of Science ®Google Scholar
• Nelson DB, Tam AL, Mitchell KG, et al. Local recurrence after microwave ablation of lung malignancies: a systematic review. Ann Thorac Surg. 2019;107(6):1876–1883.
   PubMed Web of Science ®Google Scholar
• Liu H, Steinke K. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study. J Med Imaging Radiat Oncol. 2013;57(4):466–474.
   PubMed Web of Science ®Google Scholar
• Lu DS, Raman SS, Vodopich DJ, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol. 2002;178(1):47–51.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Worst TS, Naguib NN, et al. Factors influencing local tumor control in patients with neoplastic pulmonary nodules treated with microwave ablation: a risk-factor analysis. AJR Am J Roentgenol. 2013;200(3):665–672.
   PubMed Web of Science ®Google Scholar
• Xu S, Qi J, Li B, et al. Survival prediction for non-small cell lung cancer patients treated with CT-guided microwave ablation: development of a prognostic nomogram. Int J Hyperthermia. 2021;38(1):640–649.
   PubMed Web of Science ®Google Scholar
• Xu S, Qi J, Li B, et al. Risk prediction of pneumothorax in lung malignancy patients treated with percutaneous microwave ablation: development of nomogram model. Int J Hyperthermia. 2021;38(1):488–497.
   PubMed Web of Science ®Google Scholar
• Xu S, Qi J, Li B, et al. Risk prediction of pleural effusion in lung malignancy patients treated with CT-guided percutaneous microwave ablation: a nomogram and artificial neural network model. Int J Hyperthermia. 2021;38(1):220–228.
   PubMed Web of Science ®Google Scholar
• Lim W, Ridge CA, Nicholson AG, et al. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018;8(7):709–718.
   PubMed Web of Science ®Google Scholar
• Xu S, Bie ZX, Li YM, et al. A comparative study of cavitary and noncavitary non-small cell lung cancer patients treated with CT-guided microwave ablation. J Vasc Interv Radiol. 2021;32(8):1170–1178.
   PubMed Web of Science ®Google Scholar
• Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol. 2008;15(6):1765–1774.
   PubMed Web of Science ®Google Scholar
• Brace CL, Hinshaw JL, Laeseke PF, et al. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009;251(3):705–711.
   PubMed Web of Science ®Google Scholar
• Pusceddu C, Melis L, Sotgia B, et al. Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: a preliminary report. Oncol Lett. 2019;18(1):659–666.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110(6):758–763.
   PubMed Web of Science ®Google Scholar
• Zhong L, Sun S, Shi J, et al. Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation. J Thorac Dis. 2017;9(3):590–597.
   PubMed Web of Science ®Google Scholar
• Ni X, Han JQ, Ye X, et al. Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC. Onco Targets Ther. 2015;8:3227–3235.
   PubMed Web of Science ®Google Scholar
• Healey TT, March BT, Baird G, et al. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol. 2017;28(2):206–211.
   PubMed Web of Science ®Google Scholar
• Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247(3):871–879.
   PubMed Web of Science ®Google Scholar
• Huang L, Han Y, Zhao J, et al. Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg. 2011;39(3):348–351.
   PubMed Web of Science ®Google Scholar
• Okuma T, Matsuoka T, Yamamoto A, et al. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol. 2010;33(4):787–793.
   PubMed Web of Science ®Google Scholar
• Gillams AR, Lees WR. Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol. 2008;18(4):672–677.
   PubMed Web of Science ®Google Scholar
• Lee JM, Youk JH, Kim YK, et al. Radio-frequency thermal ablation with hypertonic saline solution injection of the lung: ex vivo and in vivo feasibility studies. Eur Radiol. 2003;13(11):2540–2547.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Roman A, Nour-Eldin NA, et al. A comparison between 915 MHz and 2450 MHz microwave ablation systems for the treatment of small diameter lung metastases. Diagn Interv Radiol. 2018;24(1):31–37.
   PubMed Web of Science ®Google Scholar
• Markich R, Palussiere J, Catena V, et al. Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation. Eur Radiol. 2021. Online ahead of print.
   PubMed Web of Science ®Google Scholar